Genetic analysis of mechanisms of aging

Current Opinion in Genetics and Development

Volumn 6, Issue 3, 1996, Pages 366-370

  Rose, Michael R ^a   Archer, Margaret A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALLELE; ALZHEIMER DISEASE; CAENORHABDITIS ELEGANS; DISEASE PREDISPOSITION; DROSOPHILA; GENE ISOLATION; GENETIC ANALYSIS; GENETIC MODEL; HUMAN; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SHORT SURVEY;

CAENORHABDITIS ELEGANS; SACCHAROMYCES CEREVISIAE;

EID: 0029895718     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(96)80016-5     Document Type: Article

References (51)

1. Comfort A (Ed): The Biology of Senescence, third edition. London: Churchill Livingstone; 1979.
2. Finch CE (Ed): Longevity, Senescence and the Genome. Chicago: The University of Chicago Press; 1990.
3. Rose MR (Ed): Evolutionary Biology of Aging. New York: Oxford University Press; 1991.
4. Rose MR, Finch CE (Eds): Genetics and Evolution of Aging. Netherlands; Kluwer Academic Publishers; 1994.
5. Vijg J, Wei JY: Understanding the biology of aging: the key to prevention and therapy. J Am Geriatr Soc 1995, 43:426-434.
6. Smith DWE: Evolution of longevity in mammals. Mech Ageing Dev 1995, 81:51-60.
7. Takeda T, Hosokawa M, Higuchi K: Senescence-accelerated mouse (SAM). A novel murine model of aging. In The SAM Model of Senescence. Edited by Takeda T. Netherlands: Elsevier Science BV; 1994:15-21.
8. Finch CE: Comparative perspectives on phenotypic plasticity in the SAM mouse strains and other animals. In The SAM Model of Senescence. Edited by Takeda T. Netherlands: Elsevier Science BV; 1994:3-7.
9. Hosokawa M: Grading score system; a method of evaluation of the degree of senescence in Senescence-Accelerated Mouse (SAM). In The SAM Model of Senescence. Edited by Takeda T. Netherlands: Elsevier Science BV; 1994:23-28.
10. Pearl R: The Biology of Death, Being a Series of Lectures Delivered at Lowell Institute in Boston in December 1920. Edited by Pearl R. Philadelphia and London: JB Lippincott; 1922.
11. Phelan JP: Genetic variability and rodent models of human aging. Exp Gerontol 1992, 27:147-159.
12. Nagai J, Lin CY, Sabour MP: Lines of mice selected for reproductive longevity. Growth Dev Aging 1995, 59:79-91. This paper reports the creation of the first mouse system with postponed aging. Two lines of mice were selected for reproductive longevity and were compared with an unselected control line. This is material of great promise for the causal analysis of mammalian aging.
13. Tatar M, Carey JR: Genetics of mortality in the bean beetle Callosobruchus maculatus. Evolution 1994, 48:1371-1376.
14. Nusbaum TJ, Rose MR: Aging in Drosophila. Comparative Biochemistry and Physiology 1994, 109:33-38.
15. Draye X, Lints FA: Geographic variations of life history strategies in Drosophila melanogaster II. Analysis of laboratory-adapted populations. Exp Gerontol 1995, 30:517-532.
16. Baret P, Lints F: Selection for increased longevity in Drosophila melanogaster: a new interpretation. Gerontology 1993, 39:252-259.
17. Fukui HH, Pletcher SD, Curtsinger JW: Selection for increased longevity in Drosophila melanogaster: a response to Baret and Lints. Gerontology 1995, 41:65-68.
18. Arking R, Buck S: Selection for increased longevity in Drosophila melanogaster: a reply to Lints. Gerontology 1995, 41:69-76.
19. Carey JR, Liedo P, Vaupel JW: Mortality dynamics of density in the Mediterranean fruit fly. Exp Gerontol 1995, 30:605-629.
20. Curtsinger JW: Density and age-specific mortality. Genetica 1995, 96:179-182.
21. Curtsinger JW: Density, mortality, and the narrow view. Genetica 1995, 96:187-189.
22. Graves JL, Mueller LD: Population density effects on longevity revisited. Genetica 1995, 96:183-186.
23. Chippindale AK, Hoang DT, Service PM, Rose MR: The evolution of development in Drosophila melanogaster selected for postponed senescence. Evolution 1994, 48:1880-1899. This work demonstrated that development and aging can evolve independently if there is no correlated selection between the two, refuting the developmental theory of aging.
24. Zwaan BJ, Bijlsma R, Hoekstra RF: Artificial selection for developmental time in Drosophila melanogaster in relation to the evolution of aging: direct and correlated responses. Evolution 1995, 49:635-648. Three replicated lines selected for fast and slow larval development were created from a wild-type strain of Drosophila melanogaster. The results of this research also showed the independence of aging from development in the genus Drosophila.
25. Dudas SP, Arking R: The expression of the EF1α, genes of Drosophila is not associated with the extended longevity phenotype in a selected long-lived strain. Exp Gerontol 1994, 29:645-657.
26. Stearns SC, Kaiser M: The effects of enhanced expression of elongation factor EF-1α on lifespan in Drosophila melanogaster. Genetica 1993, 91:167-182.
27. Nikitin AG, Woodruff RC: Somatic movement of the mariner transposable element and life span of Drosophila species. Mutat Res 1995, 338:43-49.
28. Woodruff RC, Nikitin AG: P DNA element movement in somatic cells reduces life span in Drosophila melanogaster: evidence in support of the somatic mutation theory of aging. Mutat Res 1995, 338:35-42.
29. Konac T, Bozcuk AN, Kence A: The effect of hybrid dysgenesis on life span of Drosophila. Age 1995, 18:19-23.
30. Larsen PL, Albert PS, Riddle DL: Genes that regulate both development and longevity in Caenorhabditis elegans. Genetics 1995, 139:1567-1583. A genetic analysis of multiple mutations affecting aging and development in the powerful nematode model system. Perhaps constituting the most advanced genetic analysis of aging yet accomplished.
31. Vanfleteren JR, Vreese AD: Analysis of the proteins of aging Caenorhabditis elegans by high resolution two-dimensional gel electrophoresis. Electrophoresis 1994, 15:289-296.
32. Vanfleteren JR, Vreese AD: The gerontogenes age-1 and daf-2 determine metabolic rate potential in aging Caenorhabditis elegans. FASEB J 1995, 9:1355-1361.
33. Darr D, Fridovich I: Adaptation to oxidative stress in young, but not in mature or old, Caenorhabditis elegans, Free Radic Biol Med 1995, 18:195-201.
34. Kennedy BK, Austriaco NR, Zhang J, Guarente L: Mutation in the silencing gene SIR4 can delay aging in S. cerevisiae. Cell 1995, 80:485-496. This study uses stress to screen for enhanced lifespan mutations and is analogous to earlier work with Drosophila. Stress resistance may be one of the few important unifying mechanisms that determine aging patterns. This is one of the few genetic studies of aging that makes some progress in addressing the mechanistic basis of postponed aging at the molecular level.
35. Sun J, Kale SP, Childress AM, Pinswasdi C, Jazwinski SM: Divergent roles of RAS1 and RAS2 in yeast longevity. J Biol Chem 1994, 269:18638-18645.
36. Rabizadeh S, Gralla EB, Borchelt DR, Gwinn R, Valentine JS, Sisodia S, Wong P, Lee M, Hahn H, Bredesen DE: Mutations associated with amyotrophic sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sci USA 1995, 92:3024-3028.
37. Borchelt DR, Guarnieri M, Wong PC, Lee MK, Slunt HS, Xu Z, Sisodia SS, Price DL, Clevland DW: Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function. J Biol Chem 1995, 270:3234-3238.
38. Schellenberg GD, Bird TD, Wijsman EM, Orr HT, Anderson L, Nemens E, White JA, Bonnycastle L, Weber JL, Alonso ME et al.: Genetic linkage evidence for a familial Alzheimer disease locus on chromosome 14. Science 1992, 258:668-671.
39. St George-Hyslop P, Haines J, Rogaev E, Mortilla M, Vaula G, Pericak-Vance M, Foncin J-F, Montesi M, Bruni A, Sorbi S et al.: Genetic evidence for a novel familial Alzheimer disease locus on chromosome 14. Nat Genet 1992, 2:330-334.
40. Van Broeckhoven C, Backhoven H, Cruts M, De Winter G, Bruyland M, Cras P, Martin J: Mapping of a gene predisposing to early-onset Alzheimer disease to chromosome 14q24.3. Nat Genet 1992, 2:335-339.
41. Sherrington R, Rogaev El, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, LI G, Holman K et al.: Cloning of a gene bearing missen se mutations in early-onset familial Alzheimers disease. Nature 1995, 375:754-760. Cloning has supported the involvement of candidate gene AD3 in early onset (30-60 years) cases, where the gene has been mapped to chromosome 14q24.3. This paper shows that transcript S182 from this region is the most likely candidate gene, because its missense mutations co-segregate with AD.
42. Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard KAB, Weber JL, Bird TD, Schellenberg: A familial Alzheimers disease locus on chromosome 1. Science 1995, 269:970-973.
43. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu C, Jondro PD, Schmidt SD, Wang K et al.: Candidate gene for the chromosome 1 familial Alzheimers disease locus. Science 1995, 269:973-977. This locus has been identified as gene STM2, which shares homology with S182 from chromosome 14. AD arising from chromosome 1 is late in onset, causing problems of phenocopies having different aetiology.
44. Hyman BT, West HL, Rebeck GW, Buldyrev SV, Mantegna RN, Ukleja M, Havlin S, Stanley HE: Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21. Proc Natl Acad Sci USA 1995, 92:3586-3590.
45. Lehtimaki T, Pirttila T, Mehta PD, Wisniewski HM, Frey H, Nikkari T: Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer disease. Hum Genet 1995, 95:39-42.
46. Bennett C, Crawford F, Osborne A, Diaz P, Hoyne J, Lopez R, Roques P, Duara R, Rossor M, Mullan M: Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer disease but is not causative. Am J Med Genet 1995, 60:1-6. This study indicates that only the rate of progression, and not the predisposition to AD, is modulated by apoE genotype, directing our attention to the involvement of other loci.
47. Nasir J, Floresco SB, Okusky JR, Diewert VM, Richman JM, Zeisler J, Borowski A, Marth JD, Philips AG, Hayden MR: Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 1995, 81:811-823.
48. Lin BY, Nasir J, Kalchman MA, McDonald H, Zeisler J, Goldberg P, Hayden MR: Structural analysis of the 5′ region of mouse and human Huntington disease genes reveals conservation of putative promotor region and di- and trinucleotide polymorphisms. Genomics 1995, 25:707-715.
49. Benitez J, Fernandez E, Ruiz PG, Robledo M, Ramos C, Yebenes J: Trinucleotide (CAG) repeat expansion in chromosomes of Spanish patients with Huntington's disease. Hum Genet 1994, 94:563-564.
50. Lucotte G, Turpin JC, Riess O, Epplen JT, Siedlaczk, Loirat F, Hazout S: Confidence intervals for predicted age of onset, given the size of (CAG)n repeat in Huntington's disease. Hum Genet 1995, 95:231-232.
51. Yu C, Oshima J, Fu Y, Wijsman EM, Hisama F, Alisch R, Matthews S, Nakura J, Miki T, Ouais S et al.: Positional cloning of the Werner's syndrome gene. Science 1996, 272:258-262.